Prestige Consumer Healthcare Q2 FY27 net income drops 40% to $25.3 million

Bitget2026/11/05 11:03

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Prestige Consumer Healthcare’s FY27 second-quarter diluted earnings fell 38% year over year to $0.53 per share.
Quarterly revenue climbed 23% to $336.3 million, including a $65.1 million contribution from the Breathe Right portfolio and LaCorium acquisitions.
First-half operating cash flow dropped 20% year over year to $108.65 million.
Clear Eyes production variability at Pillar5 is expected to reduce product availability and revenue in the second half of FY27.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prestige Consumer Healthcare Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611050600PRIMZONEFULLFEED9871028) on November 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Prestige Consumer Healthcare Q2 FY27 net income drops 40% to $25.3 million

You may also like

Crypto prices